Effectiveness and adverse effects of methylphenidate treatment in children diagnosed with disruptive mood dysregulation disorder and attention-deficit hyperactivity disorder: a preliminary report

Gonca OzyurtDepartment of Child and Adolescent Psychiatry, Nevsehir State Hospital, Nevsehir, TurkeyCorrespondence[email protected]

Neslihan EmirogluDepartment of Child and Adolescent Psychiatry, School of Medicine, Dokuz Eylul University, Izmir, Turkey

Burak BaykaraDepartment of Child and Adolescent Psychiatry, School of Medicine, Dokuz Eylul University, Izmir, Turkey

Aynur Akay PekcanlarDepartment of Child and Adolescent Psychiatry, School of Medicine, Dokuz Eylul University, Izmir, Turkey

References

Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–948. doi: 10.1176/ajp.2007.164.6.942
PubMed Web of Science ®Google Scholar
Margulies DM, Weintraub S, Basile J, et al. Will disruptive mood dysregulation disorder reduce false diagnosis of bipolar disorder in children? Bipolar Disord. 2012;14(5):488–496. doi: 10.1111/j.1399-5618.2012.01029.x
Web of Science ®Google Scholar
Ahmann PA, Waltonen SJ, Olson KA, et al. Placebo-controlled evaluation of Ritalin side effects. Pediatrics. 1993;91(6):1101–1106.
PubMed Web of Science ®Google Scholar
Childress AC, Arnold V, Adeyi B, et al. The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial. J Atten Disord. 2014;18(2):123–132. doi: 10.1177/1087054712448252
Web of Science ®Google Scholar
Manos MJ, Brams M, Childress AC, et al. Changes in emotions related to medication used to treat ADHD. Part I: literature review. J Atten Disord. 2011;15(2):101–112. doi: 10.1177/1087054710381230
PubMed Web of Science ®Google Scholar